Status:
COMPLETED
The Safety of Vardenafil in Patients Undergoing Cardiac Surgery
Lead Sponsor:
McGuire Research Institute
Conditions:
Ischemia-reperfusion Injury.
Eligibility:
All Genders
18-90 years
Phase:
PHASE1
Brief Summary
The purpose of this study is to evaluate the safety of vardenafil in cardiac surgery patients.
Eligibility Criteria
Inclusion
- undergoing cardiac surgery
Exclusion
- emergent surgery
- recent MI in past 7 days prior to surgery
- ejection fraction \< 35%
- creatinine \> 2.0
- prior CVA
- severe COPD
- recent use of nitrates (within past 48 hours prior to surgery)
- prior CABG
- pregnancy
Key Trial Info
Start Date :
December 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2011
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT01260285
Start Date
December 1 2010
End Date
October 1 2011
Last Update
November 4 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
McGuire VAMC
Richmond, Virginia, United States, 23249